Most guidelines on breast cancer surveillance for BRCA1 and BRCA2 P/LP variant carriers recommend starting breast screening at 25 years or individualizing the screening according to family history if a breast cancer diagnosis before age 30 is present [8,158]. This evidence concerns the gene BRCA2 and breast carcinoma.